Flash Glucose Monitoring Market - Top Companies and Manufacturers

  • Report ID: 427
  • Published Date: Dec 06, 2024
  • Report Format: PDF, PPT

Companies Dominating the Flash Glucose Monitoring Landscape

    • Novo Nordisk A/S
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • DexCom, Inc.
    • GlySens Incorporated
    • Medtronic plc
    • Insulet Corporation
    • Ypsomed Holding AG
    • F. Hoffmann-La Roche Ltd
    • Abbott Laboratories
    • Tandem Diabetes Care, Inc.
    • ForaCare, Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • DexCom, Inc. announced the its new device-ONE Continuous Glucose Monitoring System, is slated for release in United Kingdom in this May. In the UK, Dexcom ONE is estimated to be a more affordable and accessible real-time CGM (rt-CGM) system for people with diabetes.
  • Novo Nordisk A/S announced that Ozempic 2.0 mg has been approved by the US Food and Drug Administration (FDA). Ozempic has now been approved for treating type 2 diabetes in adults at doses of 0.5 mg, 1.0 mg, and 2.0 mg in the United States.

Author Credits:  Radhika Pawar


  • Report ID: 427
  • Published Date: Dec 06, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of flash glucose monitoring is evaluated at USD 16.61 million.

The flash glucose monitoring market size was over USD 15.53 million in 2024 and is projected to reach USD 45.94 million by 2037, growing at around 8.7% CAGR during the forecast period i.e., between 2025-2037. Worldwide rising incidences of chronic diseases, and growing improvement in glycemia in higher risk patients with the use of flash glucose monitoring, will drive the market growth.

North America industry is estimated to hold largest revenue share of 40% by 2037, backed by changing lifestyle, rising prevalence of obesity, rising healthcare expenditure, and increasing cases of diabetes in the region

The major players in the market are Novo Nordisk A/S, DexCom, Inc., GlySens Incorporated, Medtronic plc, Insulet Corporation, Ypsomed Holding AG, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Tandem Diabetes Care, Inc., ForaCare, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample